Company: IMCR
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001671927-25-000006
Chunk: 22

Company: Immunocore Holdings plc
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 22
---
13,358)— (1,769)Net cash provided by financing activities343,881 34,346 145,442 Increase in net cash and cash equivalents14,813 31,861 94,036 Net foreign exchange difference on cash held(1,708)8,293 (12,646)Cash and cash equivalents at beginning of year442,626 402,472 321,082 Cash and cash equivalents at end of year$455,731 $442,626 $402,472 Supplemental cash flow informationCash (paid)/ received for interest, net(9,235)5,674 (4,482)Cash paid for income taxes, net(510)(977)(765)

The accompanying notes form an integral part of these consolidated financial statements.

F-8